Big Data is the Future of Health. We participated in South Summit 2019
The fourth South Summit, the biggest European event focused on innovation and
entrepreneurship, took place in Madrid during the first week of October.
The purpose of this annual event is to gather together entrepreneurs, investors, startups, and corporations in order to connect them with the most innovative business opportunities.
3rd National Symposium regarding Real-World Data in Oncology: Breaking new ground
On September 20th and 21st, numerous experts in the field of oncology gathered in León for the 3rd National Symposium about Real-World Data in Oncology (OncoRWD). Given its relevance and our current work at Persei vivarium along this line, we could not miss this event.
Patient Programs: Improving the pathologies management
It’s increasingly important that the patient remain active and informed about their pathology and treatment allowing them to have greater control over the same. To achieve this, we deploy what are known as “patient programs”, specific patient support programs, which provides information according to where the patient is on their journey.
Presentation of allergy project in collaboration with OSASEN, FAES FARMA, and Quirónsalud
In July, the Palacio Euskalduna hosted the celebration of the BIND 4.0 (Basque Industry 4.0 Accelerator Program) “Demo Day.” This is a disruptive event that gave the thirty-two technological startups participating in this acceleration program an opportunity to present their industrial projects of the future
The Digital Health Startup Experience
The Digital Health market has been experiencing unprecedented growth. Just by looking at the investment volume of the past few years, we will notice that Digital Health startups have gone from attracting $5.5 billion in 2016 to a total funding volume of more than $8 billion in 2018. This represents more than an 80% growth rate in two years’ time.
Technology and the patient are keys to the future of clinical studies
Currently, there is a growing emphasis on complementing traditional clinical trials with studies based on Real-World Data (RWD). These studies have an enormous potential with the information provided by the individual patient (patient-reported outcome measures and patient-reported experience measures: PROMs and PREMs).